Zobrazeno 1 - 10
of 295
pro vyhledávání: '"Clinical cure"'
Autor:
Yuying Li, Siqi Yang, Cong Li, Zhenjie Ma, Mengmeng Zhang, Wenhang Zou, Zihao Wu, Haiyan Hou, Weixing Wang, Liying Zhu
Publikováno v:
Virology Journal, Vol 21, Iss 1, Pp 1-9 (2024)
Abstract Purpose Peginterferon alfa-2b (Peg-IFN α-2b) has demonstrated superior efficacy over nucleos(t)ide analogs (NAs) in the treatment of chronic hepatitis B (CHB), particularly among patients with low levels of hepatitis B surface antigen (HBsA
Externí odkaz:
https://doaj.org/article/16deed8fddd645a9b4ee0c28934269ff
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
BackgroundPegylated interferon-α (PEG-IFN-α) therapy could decrease hepatitis B surface antigen (HBsAg) and improve long-term prognosis of hepatitis B virus (HBV) infection. However, studies on safety and efficacy of PEG-IFN-α for patients with HB
Externí odkaz:
https://doaj.org/article/9bcec2c0ac104dae911ddf951f2417c6
Autor:
Ryan K. Shields, Juan P. Horcajada, Shweta Kamat, Paurus M. Irani, Margaret Tawadrous, Tobias Welte
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 7, Pp 1639-1664 (2024)
Abstract Introduction Ceftazidime-avibactam (CAZ-AVI) is a combination of the third-generation cephalosporin ceftazidime and the novel, non-β-lactam β-lactamase inhibitor avibactam that is approved for the treatment of pediatric (≥ 3 months) and
Externí odkaz:
https://doaj.org/article/27b528581cc349a1ae69061d90b019cf
Autor:
Charles-Hervé Vacheron, Anne Kaas, Jean-Philippe Rasigade, Frederic Aubrun, Laurent Argaud, Baptiste Balanca, Jean-Luc Fellahi, Jean Christophe Richard, Anne-Claire Lukaszewicz, Florent Wallet, Olivier Dauwalder, Arnaud Friggeri
Publikováno v:
Annals of Intensive Care, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Background The efficacy and safety of cefiderocol in ICU patients with difficult-to-treat resistance (DTR) non-fermenting Gram-negative bacteria (Nf-GNB) are not as well-established. Consequently, we conducted a cohort study to compare Cefid
Externí odkaz:
https://doaj.org/article/5906475ef8ce4131a102da711cd283ba
Autor:
Sultan Alotaibi, Nader Damfu, Ahmed Alnefaie, Abdullah Alqurashi, Sami Althagafi, Aown Alotaibi, Musim Alotaibi, Abdullah Alsuwat
Publikováno v:
Pharmacy, Vol 12, Iss 5, p 147 (2024)
Background: Obesity is considered a health issue associated with increased morbidity and a risk factor for multiple conditions, such as type 2 diabetes, cardiovascular diseases and infections. It may affect the pharmacokinetics and pharmacodynamics o
Externí odkaz:
https://doaj.org/article/5d1c21d1dfa947abb50c42fb77a22248
Autor:
Chaojing Wen, Yixuan Wang, Haoyue Tian, Yu Lei, Zhiyi Wang, Dachuan Cai, Zhi Zhou, Xiaofeng Shi
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 13 (2024)
BackgroundAmong the advantaged population with clinical cure of chronic hepatitis B, chronic inactive hepatitis B virus carriers (IHCs) and nucleoside analog-experienced patients have similar serological manifestations. This study established non-int
Externí odkaz:
https://doaj.org/article/21580a53fb474615a7b571f5d236b389
Autor:
Li-Li Wu, Xiao-Yan Li, Kai Deng, Bing-Liang Lin, Hong Deng, Dong-Ying Xie, Geng-Lin Zhang, Qi-Yi Zhao, Zhi-Shuo Mo, Yue-Hua Huang, Zhi-Liang Gao
Publikováno v:
Liver Research, Vol 7, Iss 2, Pp 136-144 (2023)
Background and aims: The primary goal of chronic hepatitis B (CHB) treatment is to reduce hepatitis B surface antigen (HBsAg). T helper 17 (Th17) and regulatory T (Treg) cells are essential for the development of CHB. However, how Th17 and Treg cells
Externí odkaz:
https://doaj.org/article/8d959db95e01445fb794174860636754
Autor:
Noppason Pangprasit, Anyaphat Srithanasuwan, Montira Intanon, Witaya Suriyasathaporn, Wasana Chaisri
Publikováno v:
Veterinary World, Vol 16, Iss 4, Pp 792-798 (2023)
Background and Aim: Mastitis, primarily caused by intramammary bacterial infection, is the most expensive disease in the global dairy industry due to its negative impact on milk composition and manufacturing properties. This study aimed to evaluate t
Externí odkaz:
https://doaj.org/article/62ee5a46f2cc404bb66abd3988cbac90
Publikováno v:
Open Medicine, Vol 18, Iss 1, Pp 83-6 (2023)
Chronic hepatitis B (CHB) often causes iron overload in the liver but rarely causes severe secondary hemochromatosis (SH). A 48-year-old man was infected with CHB via vertical transmission. For 21 years, nonstandard treatment with second-line hepatit
Externí odkaz:
https://doaj.org/article/ee1b8aa2c9c145d78c5470436880610b
Publikováno v:
Annals of Clinical Microbiology and Antimicrobials, Vol 21, Iss 1, Pp 1-21 (2022)
Abstract Background Bloodstream infections (BSIs), or bacteremia, are responsible for considerable disease burden. Increasing rates of antibiotic resistance and delays in selection of appropriate treatment lead to increased morbidity, mortality, and
Externí odkaz:
https://doaj.org/article/defe028665bb485ba8d9454ceba20b32